Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 7.2B | 7.9B | 7.8B |
Cost of revenue | 5.9B | 5.9B | 6.3B | 6.2B |
Gross profit | 1.4B | 1.4B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | 153.7M | 146.9M | 163.9M | 159.7M |
Selling general and admin | 74.3M | 82.0M | 68.3M | 76.8M |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 1.1B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 26.5M | 30.7M | 38.4M | 44.4M |
Expense | 121.2M | 125.5M | 111.8M | 116.1M |
Other income expense | 43.5M | -140.0M | -184.4M | -46.1M |
Pretax income | 1.1B | 907.6M | 1.2B | 1.3B |
Tax provision | 202.4M | 199.8M | 229.7M | 246.7M |
Net income | 894.8M | 707.8M | 954.5M | 1.0B |
Basic EPS | 0.8 | 0.6 | 0.8 | 0.8 |
Diluted EPS | 0.7 | 0.6 | 0.8 | 0.8 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 1.8B | 1.8B | 1.5B | 2.0B |
Net income from continuing op. | 894.8M | 707.8M | 954.5M | 1.0B |
Minority interests | -29.0M | -27.3M | -19.6M | -27.3M |
Preferred stock dividends | — | — | — | — |